Public tenders in Germany

212 open tenders

CountryTenderValueClosesDays left

Conclusion of non-exclusive drug discount agreements under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Ustekinumab (WHO ATC code: L04AC05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 343328-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

275days

Pharmaceutical Discount Agreements pursuant to Section 130a para. 8 of the German Social Code Book V (SGB V) within the framework of open-house procedures

IKK classic, DresdenTED 702716-2025

value not stated25 lots

Sun 5 Sep23:59 in Berlin

311days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Ipratropium bromide (WHO ATC Code: R03BB01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 478099-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of non-exclusive drug discount agreements under § 130a Abs. 8 SGB V via an Open-House model for the active substance Teduglutid (WHO ATC code: A16AX08)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 583104-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Epoetin alfa and Epoetin zeta (WHO ATC Code: B03XA01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 236720-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Omalizumab (WHO ATC Code: R03DX05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 473851-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active substance Epinephrine (WHO ATC-code: C01CA24) in pre-filled syringe/pen

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 534781-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Atomoxetine, excluding the pharmaceutical form solution (WHO ATC Code: N06BA09)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 449660-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active substance Epinephrine (WHO ATC-code: C01CA24) in nasal spray form

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 535909-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Certolizumab pegol (WHO ATC Code: L04AB05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 617680-2026

value not stated1 lot

Sun 31 Oct23:58 in Berlin

367days

Conclusion of non-exclusive discount agreements for medicinal products under § 130a para. 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Tacrolimus (WHO ATC code: L04AD02), limited to the dosage form

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 632634-2026

value not stated1 lot

Sun 31 Oct23:58 in Berlin

367days

Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Tacrolimus (WHO ATC Code: L04AD02)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 630574-2026

value not stated1 lot

Sun 31 Oct23:58 in Berlin

367days

Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Testosterone (WHO ATC Code: G03BA03), with Restrictions

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 617998-2026

value not stated1 lot

Sun 31 Oct23:58 in Berlin

367days

Drug Rebate Agreements pursuant to § 130a Abs. 8 SGB V within the framework of Open-House Procedures

IKK classic, DresdenTED 759734-2025

value not stated53 lots

Fri 5 Nov23:59 in Berlin

372days

Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance sodium oxybate (WHO ATC Code: N07XX04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 609690-2025

value not stated1 lot

Tue 30 Nov23:58 in Berlin

397days

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 673520-2026

value not stated1 lot

Tue 30 Nov23:58 in Berlin

397days

Conclusion not exclusive of Drug Rebate Agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active ingredient Betahistine (WHO ATC Code: N07CA01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 778877-2025

value not stated1 lot

Tue 30 Nov23:59 in Berlin

397days

Conclusion not exclusive of Drug Rebate Agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active ingredient Timolol (WHO ATC Code: S01ED01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 777378-2025

value not stated1 lot

Tue 30 Nov23:59 in Berlin

397days

Conclusion not exclusive of Drug Rebate Agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active ingredient Alfacalcidol (WHO ATC Code: A11CC03) in the form of soft capsules

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 778035-2025

value not stated1 lot

Tue 30 Nov23:59 in Berlin

397days

Conclusion of non-exclusive agreements for medicines with the active substance Relugolix (ATC code: L02BX04) under an Open-House model

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 120686-2026

value not stated1 lot

Fri 31 Dec23:58 in Berlin

428days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.